Johnson & Johnson (JNJ) Stock Price, Quote & News

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 732 524 0400

Website: www.jnj.com

Address:

One Johnson & Johnson Plaza, New Brunswick, United States

Outcomes Sep. 10 at 12:54 PM

$IBRX $MRNA $MRK $PFE $JNJ mRNA BAD. 'Turbo-cancers' PSS KNOWS. https://x.com/echotoall/status/2098027061835100621?s=20

0 · Reply

Quantumup Sep. 10 at 10:12 AM

Jefferies y'day reiterated $CMPS Buy-$18 and said -- We are 75-85%+ confident FDA approves COMP360 for TRD $JNJ $LLY STIM GHRS HELP DFTX Oppenheimer y'day reiterated Compass Outperform-$20 Stifel y'day reiterated Compass Buy-$21 Here's what Jefferies, Oppenheimer and Stifel said in their notes to investors: https://x.com/Quantumup1/status/2097991311122989319?s=20

3 · Reply

MarcoFla99 Sep. 10 at 2:30 AM

$JNJ Sold 10% of my holdings today.

0 · Reply

dustlesspuma Sep. 9 at 9:10 PM

🔴 $JNJ 265P Sep 11 💰 $589,400 premium 💵 $0.9/contract 📊 9.9x Vol/OI 📍 Spot $269.04 💰 Large premium 🌊 Dark Flow | Options Flow

0 · Reply

Outcomes Sep. 9 at 8:58 PM

$IBRX $MRNA $MRK $PFE $JNJ Cardiac, oncologic, neurologic, immunologic.. mRNA BAD. SAVE THE CHILDREN. 🙏🏻 PSS KNOWS. https://x.com/fynnderella1/status/2097697348486860895?s=46

1 · Reply

SellasgpsCurativeBAT11 Sep. 9 at 6:47 PM

$SLS $JNJ $MRK Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September 1, 2026. Mr. Cavanaugh officially took over last week. $JNJ Executives openly praising GPS Regal Pivotal Registrational Phase 3. 👇 ✌️🙏❤️‍🩹

0 · Reply

Gebinator Sep. 9 at 6:43 PM

$SLS while we marvel over the funny trading patterns of late, for entertainment and survey sampling value, let's explore those BPs chasing $JNJ and $MRK for some form of m&a transaction with $SLS. Who's the viable, reliable third (spoiler) for the 🏆

0 · Reply

Johnmtnb2018 Sep. 9 at 5:19 PM

$SLS $JNJ Keep an eye on JNJ. Katherine Kalin Bach is up to something very big !

0 · Reply

juice_rock Sep. 9 at 4:56 PM

$JNJ Based on the conference call today I'm predicting $JNJ buys out $SLS for the oncology portfolio upon release of successful REGAL trial data. Specifically: >JNJ wants solutions to "Unmet needs" in the context of oncology >JNJ wants to bring scalability that isn't there if the acquisition partner continues independently.

7 · Reply

juice_rock Sep. 9 at 3:43 PM

$SLS Just now on the $JNJ call with wells fargo healthcare conference, $JNJ regarding oncology acquisitions: >has the cashpile to make deals happen >Looking for solutions to unmet needs >JNJ wants to bring scalability that isn't there if the acquisition target continues independent I wonder who that could be??? 🤔🤔🤔🤔

2 · Reply

Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX

Sep 10, 2026, 7:45 AM EDT - 2 hours ago

Johnson & Johnson Receives CE Marking for ACUVUE OASYS MAX Reusable Contact Lenses

2026-09-10T10:25:41.000Z - 3 hours ago

Johnson & Johnson price target raised to $320 from $290 at HSBC

Sep 9, 2026, 11:00 AM EDT - 22 hours ago

Johnson & Johnson Transcript: Wells Fargo 21st Annual Healthcare Conference

Sep 8, 2026, 8:00 AM EDT - 2 days ago

Johnson & Johnson spotlights new neuropsychiatry data across bipolar mania, depression and schizophrenia at Psych Congress 2026

Sep 2, 2026, 4:21 PM EDT - 7 days ago

Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit

2026-09-02T11:35:52.000Z - 8 days ago

Johnson & Johnson assumed with a Buy at UBS

Aug 31, 2026, 5:08 PM EDT - 9 days ago

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

Aug 27, 2026, 5:42 AM EDT - 14 days ago

China approves J&J's oral psoriasis pill, says drugmaker

Aug 24, 2026, 7:12 PM EDT - 16 days ago

FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients

Aug 24, 2026, 6:33 PM EDT - 16 days ago

US FDA expands approval for J&J's drug for rare blood disorder

Aug 24, 2026, 12:20 PM EDT - 16 days ago

Louisiana Jury Issues $10 Million Verdict in Talc-Related Mesothelioma Case Against Johnson & Johnson

2026-08-19T22:09:27.000Z - 21 days ago

Analysts Back Dividend Aristocrats JNJ and LIN Ahead of Q3 Earnings

LIN

2026-08-17T10:16:04.000Z - 24 days ago

Oppenheimer upgrades Intuitive Surgical on lack of U.S. competition

ISRG

Aug 13, 2026, 11:15 PM EDT - 27 days ago

Expert explains why healthcare is a top-performing sector

ABBV AMGN BIIB GILD LLY MRK UNH

Aug 10, 2026, 4:27 PM EDT - 4 weeks ago

Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Aug 6, 2026, 6:23 PM EDT - 4 weeks ago

Jim Cramer highlights 5 investing themes — and the stocks to buy for each

AMAT AXP COF CRWD GS KLAC LLY

Aug 4, 2026, 4:05 PM EDT - 5 weeks ago

Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference

Aug 4, 2026, 8:45 AM EDT - 5 weeks ago

Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September

Aug 3, 2026, 8:00 AM EDT - 5 weeks ago

Johnson & Johnson Transcript: Investor update

Aug 2, 2026, 8:00 AM EDT - 5 weeks ago

Inside J&J's Lab to Create a Simpler Robotic Surgery Device

Jul 30, 2026, 8:30 AM EDT - 6 weeks ago

Johnson & Johnson's RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer

Jul 29, 2026, 6:13 PM EDT - 6 weeks ago

Johnson & Johnson Comes to Strategic Agreement with Sail Biomedicines

Jul 29, 2026, 5:42 PM EDT - 6 weeks ago

Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation

Jul 29, 2026, 5:38 PM EDT - 6 weeks ago

Johnson & Johnson lowers 2026 profit forecast

Jul 29, 2026, 5:28 PM EDT - 6 weeks ago

Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset

Jul 29, 2026, 12:01 PM EDT - 6 weeks ago

Explainer: Can J&J finally put the talc litigation behind it?

Jul 28, 2026, 4:31 PM EDT - 6 weeks ago

Johnson & Johnson offers $5.5 billion to settle remaining lawsuits over talc products linked to cancer

Jul 28, 2026, 12:26 PM EDT - 6 weeks ago

Johnson & Johnson agrees to pay $5.5B to settle talc lawsuits

Jul 28, 2026, 1:03 AM EDT - 6 weeks ago

Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit

Jul 28, 2026, 12:31 AM EDT - 6 weeks ago

J&J offers $5.5bn to settle baby powder lawsuits

Jul 27, 2026, 9:29 PM EDT - 6 weeks ago

Johnson & Johnson Agrees to Pay $5.5 Billion to Settle Talc Lawsuits

Jul 27, 2026, 6:47 PM EDT - 6 weeks ago

Johnson & Johnson announces $5.5 billion settlement of talc lawsuits

Jul 27, 2026, 6:31 PM EDT - 6 weeks ago

Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation

Jul 27, 2026, 5:45 AM EDT - 6 weeks ago

Robert Kiyosaki sees a brutal depression ahead: 3 stocks that may protect portfolios

NEM WMT

$TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma$

Jul 23, 2026, 8:30 AM EDT - 7 weeks ago

TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma

Jul 22, 2026, 4:33 PM EDT - 7 weeks ago

US judge casts doubt on 69,000 cases alleging J&J talc caused cancer

Jul 22, 2026, 7:21 AM EDT - 7 weeks ago

Johnson & Johnson's robotic surgery device gets US FDA marketing authorization

Jul 22, 2026, 7:00 AM EDT - 7 weeks ago

Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System

Jul 21, 2026, 6:30 PM EDT - 7 weeks ago

Jim Cramer says this old-school investing concept still wins — even in the AI boom

BNY CVS GS MMM WFC

Jul 16, 2026, 8:11 AM EDT - 1 month ago

Johnson & Johnson Announces Collaboration with TIME to Introduce New Healthcare Champion of the Year Award

Jul 16, 2026, 8:00 AM EDT - 1 month ago

DePuy Synthes Acquires Expanding Innovations™

Jul 15, 2026, 12:09 PM EDT - 1 month ago

J&J Leverages AI and Robots to Target $100 Billion in Annual Revenue

Jul 15, 2026, 8:30 AM EDT - 1 month ago

Johnson & Johnson Earnings Call Transcript: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 1 month ago

Johnson & Johnson Slides: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 1 month ago

Johnson & Johnson Earnings release: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 1 month ago

Johnson & Johnson Quarterly report: Q2 2026

Jul 15, 2026, 7:27 AM EDT - 1 month ago

ASML, Intel, Johnson & Johnson, and More Stocks That Explain Today's Market

ASML INTC

Jul 15, 2026, 6:35 AM EDT - 1 month ago

Johnson & Johnson Hikes Guidance, Stock Falls

Jul 15, 2026, 6:33 AM EDT - 1 month ago

Johnson & Johnson Bumps Up Guidance as Sales Rise

Jul 15, 2026, 6:25 AM EDT - 1 month ago

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2026

Jul 15, 2026, 6:23 AM EDT - 1 month ago

J&J quarterly earnings beat Wall Street estimates on strength of medicines unit

Jul 15, 2026, 6:20 AM EDT - 1 month ago

Johnson & Johnson reports Q2 2026 results, raises 2026 outlook

Jul 9, 2026, 1:00 PM EDT - 2 months ago

The Big 3: UNH, KO, JNJ

KO UNH

Jul 8, 2026, 7:45 AM EDT - 2 months ago

Johnson & Johnson Announces FDA Approval for the Dual Energy THERMOCOOL SMARTTOUCH SF Platform

Jul 6, 2026, 6:29 PM EDT - 2 months ago

Jim Cramer says these are the 5 stocks to buy during this market rotation

PEP SBUX STZ TJX

Jun 26, 2026, 2:39 PM EDT - 2 months ago

Healthcare stocks have become a haven for investors ditching tech

ABBV ABSI APGE LLY MRNA SNY XBI

Jun 26, 2026, 12:35 PM EDT - 2 months ago

Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

Jun 25, 2026, 5:00 AM EDT - 2 months ago

Johnson & Johnson Advances Cardiac Ablation Technology in Europe with Availability of Dual Energy THERMOCOOL SMARTTOUCH SF Platform

Jun 15, 2026, 6:00 AM EDT - 2 months ago

Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida

$New TALVEY®▼(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma$

Jun 13, 2026, 6:41 AM EDT - 2 months ago

New TALVEY®▼(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma

Outcomes Sep. 10 at 12:54 PM

$IBRX $MRNA $MRK $PFE $JNJ mRNA BAD. 'Turbo-cancers' PSS KNOWS. https://x.com/echotoall/status/2098027061835100621?s=20

0 · Reply

Quantumup Sep. 10 at 10:12 AM

3 · Reply

MarcoFla99 Sep. 10 at 2:30 AM

$JNJ Sold 10% of my holdings today.

0 · Reply

dustlesspuma Sep. 9 at 9:10 PM

🔴 $JNJ 265P Sep 11 💰 $589,400 premium 💵 $0.9/contract 📊 9.9x Vol/OI 📍 Spot $269.04 💰 Large premium 🌊 Dark Flow | Options Flow

0 · Reply

Outcomes Sep. 9 at 8:58 PM

$IBRX $MRNA $MRK $PFE $JNJ Cardiac, oncologic, neurologic, immunologic.. mRNA BAD. SAVE THE CHILDREN. 🙏🏻 PSS KNOWS. https://x.com/fynnderella1/status/2097697348486860895?s=46

1 · Reply

SellasgpsCurativeBAT11 Sep. 9 at 6:47 PM

0 · Reply

Gebinator Sep. 9 at 6:43 PM

0 · Reply

Johnmtnb2018 Sep. 9 at 5:19 PM

$SLS $JNJ Keep an eye on JNJ. Katherine Kalin Bach is up to something very big !

0 · Reply

juice_rock Sep. 9 at 4:56 PM

7 · Reply

juice_rock Sep. 9 at 3:43 PM

2 · Reply

Outcomes Sep. 9 at 3:27 PM

$IBRX $MRNA $MRK $PFE $JNJ mRNA BAD. https://x.com/fa21519230/status/2097375843894911449?s=46

0 · Reply

SellasgpsCurativeBAT11 Sep. 9 at 2:31 PM

$SLS $JNJ $MRK $PFE $BMY . Stergiou doesn’t need to announce anything if big pharmaceutical on the table makes a move and buys them out to avoid a bidding war post data. ✌️🙏❤️‍🩹

0 · Reply

Estimize Sep. 9 at 2:09 PM

Wall St is expecting 2.90 EPS for $JNJ Q3 [Reporting 10/13 BMO] http://www.estimize.com/intro/jnj?chart=historical&metric_name=eps&utm_cont

0 · Reply

Outcomes Sep. 9 at 11:30 AM

$IBRX $MRNA $MRK $PFE $JNJ All planned. PSS KNOWS. 'Follow The Money'. William Gates Sr. was a known eugenicist Bill Gates money all over big pharmaceutical and regulatory bodies.

0 · Reply

Outcomes Sep. 9 at 11:25 AM

$IBRX $JNJ $MRK $MRNA $PFE mRNA BAD. ‘Act Of War’ ‘Emergency Use Authorization’ Hugh Auchincloss, NIH, office next to Fauci Hugh Auchincloss Sr. was oncologist in Ridgewood, NJ using experimental chemotherapy drugs. He treated my 2 sisters. Jake Auchincloss, son of Hugh Jr., congressman in Massachusetts. https://x.com/loop_rm_3117211/status/2097300713814540651?s=46

0 · Reply

Outcomes Sep. 9 at 10:55 AM

$IBRX $MRNA $MRK $PFE $JNJ mRNA BAD. PSS KNOWS. SAVE THE CHILDREN. 🙏 https://x.com/DaveFreedom4/status/2097068995505709494?s=20

1 · Reply

GJ_Rockabilt Sep. 9 at 4:46 AM

$JNJ $AMGN $AZN $GILD $PFE SEP 11 PDUFA for Midcap Oncology Biotech TLX (Friday), below.

0 · Reply

focafoca99 Sep. 8 at 1:08 PM

$JNJ spotlights new neuropsychiatry data across bipolar mania, depression and schizophrenia at Psych Congress 2026. https://www.rapidticker.com/news/jnj-johnson-johnson-spotlights-new-neuropsychiatry-f42d25

0 · Reply

harmongreg Sep. 8 at 12:52 PM

4 Trade Ideas for Johnson & Johnson: Bonus Idea $JNJ https://dragonflycap.com/4-trade-ideas-for-johnson-johnson-bonus-idea-13/

1 · Reply

Outcomes Sep. 8 at 11:31 AM

$IBRX $MRNA.X $MRK $PFE $JNJ ….why rebrand problems!? 🤔 MRNA BAD. PSS KNOWS. https://products.modernatx.com/mnexspikepro?utm_medium=paidsearch&utm_source=bing&utm_campaign=hcp1283&utm_term=65&utm_content=brandedkeywords&&msclkid=c3547d76fa4719a56b6517e9b926266b&utm_source=bing&utm_medium=cpc&utm_campaign=MODERNA_HCP%201283%20MNEXSPIKE_US_BING%20SEARCH_CONVERSION_P3JKPKP_2026_July-Oct_Traffic_CPC_Branded_%5BKNOWN%5D&utm_term=mNEXSPIKE&utm_content=HCP%20Evergreen%20-%20General&gclid=c3547d76fa4719a56b6517e9b926266b&gclsrc=3p.ds

0 · Reply

PhantomZ Sep. 6 at 9:47 PM

$TLTFF taken from AI…. A competition killer? $IBRX $CGON $MRK $JNJ https://stockhouse.com/companies/bullboard?symbol=v.tlt&postid=37107118

0 · Reply

grampslol Sep. 5 at 7:21 PM

$MNKD 31 Vice Presidents... 1 flop drug , afrezza dpi inhaled prandial insulin approved in 2014 ... the only insulin with the FDA black box warning label dumped by $SNY over a decade ago ... $JNJ $LLY $LQDA

2 · Reply

Market Cap	648.55B
Revenue (ttm)	94.19B
Net Income (ttm)	26.80B
EPS (ttm)	N/A
PE Ratio	25.34
Forward PE	23.71
Profit Margin	28.46%
Debt to Equity Ratio	0.44

Volume	6,125,000
Avg Vol	7,209,644
Day's Range	N/A - N/A
Shares Out	2.41B
Stochastic %K	19%
Beta	0.24
Analysts	Strong Sell
Price Target	$278.04